Pharma News

Scientists at Department of Biotechnology’s Thiruvananthapuram-based Rajiv Gandhi Centre for Biotechnology have developed a new system that promises to improve the delivery of growth factors to help in healing wounds.

Eisai Co., Ltd announced today that it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®,  generic name perampanel) for use in adjunctive treatment of partial onset seizures (with or without secondarily generalized seizures) in epilepsy patients 12 years of age and older.

Breast cancer is a condition that affects far too many women across the globe. More than 55,000 people in the U.K. are diagnosed with breast cancer each year, and about 1 in 8 women in the U.S. will develop the disease in their lifetime.

A new study shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE). The study, which demonstrated the effectiveness of direct delivery of gene therapy into the brain of a mouse model of CTE, is published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Bhubaneswar-based Institute of Life Sciences, an autonomous institution under the Department of Biotechnology, has signed a collaborative agreement with All India Institute of Medical Sciences, Bhubaneswar for undertaking advanced research in the area of human health & welfare. The pact aims to strengthen partnershipbetween the two institutions in research,education and outreach.

Council of Scientific and Industrial Research-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow has transferred the five technologies of herbal formulation to Nandan Impex Private Limited (NIPL), Mumbai.

PHD Chamber in association with Ministry of AYUSH, Govt. of India and Department of AYUSH, State Govt. of Tamil Nadu inaugurated 3 day Conference cum Exhibition on 13th December 2019 at Codissia Trade Fair Complex, Coimbatore, Tamil Nadu.

Caption: L-R: Padamshree Dr. P.R. Krishna Kumar, CMD, Arya Viadya Pharmacy,  Mr. Vivek Seigell, Principal Director, PHD Chamber, Dr.  K. Kanakavali, Director General, Central Council for Research in Siddha, Chennai, Thiru S. Ganesh, IAS, Director, Indian Medicine and Homeopathy, Government of Tamil Nadu, Mr. E. V. Shiril, Chairman-Kerala Chapter, PHD Chamber.